0001385508-22-000111.txt : 20220715
0001385508-22-000111.hdr.sgml : 20220715
20220715160550
ACCESSION NUMBER: 0001385508-22-000111
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220714
FILED AS OF DATE: 20220715
DATE AS OF CHANGE: 20220715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Skolnick Phil
CENTRAL INDEX KEY: 0001358116
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38193
FILM NUMBER: 221086358
MAIL ADDRESS:
STREET 1: C/O DOV PHARMACEUTICAL, INC.
STREET 2: 433 HACKENSACK AVENUE
CITY: HACKENSACK
STATE: NJ
ZIP: 07601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OPIANT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001385508
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464744124
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 233 WILSHIRE BLVD
STREET 2: SUITE 400
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
BUSINESS PHONE: (310) 598-5410
MAIL ADDRESS:
STREET 1: 233 WILSHIRE BLVD
STREET 2: SUITE 400
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
FORMER COMPANY:
FORMER CONFORMED NAME: Lightlake Therapeutics Inc.
DATE OF NAME CHANGE: 20091009
FORMER COMPANY:
FORMER CONFORMED NAME: Madrona Ventures, Inc.
DATE OF NAME CHANGE: 20070108
4
1
wf-form4_165791552674780.xml
FORM 4
X0306
4
2022-07-14
0
0001385508
OPIANT PHARMACEUTICALS, INC.
OPNT
0001358116
Skolnick Phil
C/O OPIANT PHARMACEUTICALS, INC.
233 WILSHIRE BLVD., SUITE 400
SANTA MONICA
CA
90401
0
1
0
0
Chief Scientific Officer
Common Stock
2022-07-14
4
S
0
627
11.85
D
23818
D
These shares were sold to cover tax withholding obligations in connection with the vesting of performance stock units.
This transaction was executed in multiple trades at prices ranging from $11.03 to $11.63. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Phil Skolnick
2022-07-15